X
X4 Pharmaceuticals, Inc. (XFOR)
NCM – Real Time Price. Currency in USD
4.34
-0.16 (-3.56%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
4.34
-0.16 (-3.56%)
At close: May 12, 2026, 4:00 PM EDT
X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally small-molecule selective antagonist of chemokine receptor CXCR4, which is in phase 3 clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. It has a license agreement with Abbisko Therapeutics Co Ltd. to manufacture and distribute XOLREMDI in mainland China, Taiwan, Hong Kong and Macau; Norgine to develop, manufacture, and commercialize mavorixafor in Europe, Australia, and New Zealand; and Genzyme Corporation for CXCR4 receptor to develop and commercialize products containing licensed compounds for all therapeutic, prophylactic and diagnostic uses. The company is headquartered in Boston, Massachusetts.
| Name | Position |
|---|---|
| Dr. Adam R. Craig M.B.A., M.D., Ph.D. | Executive Chair |
| Dr. Keith T. Flaherty M.D. | Founder & Member of Corporate Advisory Board |
| Dr. Renato T. Skerlj Ph.D. | Founder |
| Dr. Richard Peters M.D., Ph.D. | Founder |
| Mr. David H. Kirske | CFO, Treasurer & Corporate Secretary |
| Mr. John P. Volpone M.B.A. | President & COO |
| Date | Type | Document |
|---|---|---|
| 2026-05-12 | 8-K | xfor-20260511.htm |
| 2026-05-06 | S-3 | xfor-2026sx3_shelfatm.htm |
| 2026-05-06 | 10-Q | xfor-20260331.htm |
| 2026-03-20 | DEF 14A | xfor-20260320.htm |
| 2026-03-18 | S-8 | a032026s-8.htm |
| 2026-03-17 | 10-K | xfor-20251231.htm |
| 2025-11-05 | 8-K | xfor-20251105.htm |
| 2025-10-27 | 8-K | xfor-20251023.htm |
| 2025-09-17 | 8-K | xfor-20250915.htm |
| 2025-09-15 | CORRESP | filename1.htm |